Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence

Journal of Behavioral Medicine

Volumn 34, Issue 2, 2011, Pages 128-138

  Meade, Christina S ^a,b,c   Conn, Nina A ^b   Skalski, Linda M ^a   Safren, Steven A ^c,d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antiretroviral therapy; Cocaine dependence; HIV AIDS; Medication adherence; Neurocognitive functioning

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COCAINE DEPENDENCE; COGNITIVE DEFECT; COMPARATIVE STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATIENT COMPLIANCE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 79952487759     PISSN: 01607715     EISSN: 15733521     Source Type: Journal    
DOI: 10.1007/s10865-010-9293-5     Document Type: Article

References (93)

1. E Aharonovich DS Hasin AC Brooks X Liu A Bisaga EV Nunes 2006 Cognitive deficits predict low treatment retention in cocaine dependent patients Drug and Alcohol Dependence 81 3 313 322 16171953 10.1016/j.drugalcdep.2005.08.003 (Pubitemid 43152458)
2. E Aharonovich E Nunes D Hasin 2003 Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment Drug and Alcohol Dependence 71 2 207 211 12927659 10.1016/S0376-8716(03)00092-9 (Pubitemid 37289030)
3. SM Albert SR Flater R Clouse G Todak Y Stern K Marder 2003 Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy AIDS and Behavior 7 3 329 338 14586194 10.1023/A:1025404105378 (Pubitemid 37203919)
4. A Ammassari A Antinori MS Aloisi MP Trotta R Murri L Bartoli, et al. 2004 Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons Psychosomatics 45 5 394 402 15345784 10.1176/appi.psy.45.5.394 (Pubitemid 39166911)
5. IC Anthony JE Bell 2008 The neuropathology of HIV/AIDS International Review of Psychiatry 20 1 15 24 18240059 10.1080/09540260701862037 1:STN:280:DC%2BD1c%2Fot1CnsA%3D%3D (Pubitemid 351196199)
6. A Antinori G Arendt JT Becker BJ Brew DA Byrd M Cherner, et al. 2007 Updated research nosology for HIV-associated neurocognitive disorders Neurology 69 18 1789 1799 17914061 10.1212/01.WNL.0000287431.88658.8b 1:STN:280: DC%2BD2snktFyqsQ%3D%3D (Pubitemid 350059308)
7. Applebaum, A. J., Otto, M. W., Richardson, M. A., & Safren, S. A. (2009). Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. Journal of Clinical and Experimental Neuropsychology, Epub ahead of print (Nov 4), 1-11.
8. AJ Applebaum LC Reilly JS Gonzalez MA Richardson CL Leveroni SA Safren 2009 The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients AIDS Patient Care and STDS 23 6 455 462 19519229 10.1089/apc.2008.0181
9. A Ardila M Rosselli S Strumwasser 1991 Neuropsychological deficits in chronic cocaine abusers International Journal of Neuroscience 57 1-2 73 79 1938157 10.3109/00207459109150348 1:STN:280:DyaK38%2FktVKiuw%3D%3D
10. JH Arnsten PA Demas RW Grant MN Gourevitch H Farzadegran AA Howard, et al. 2002 Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users Journal of General Internal Medicine 17 5 377 381 12047736 (Pubitemid 34626108)
11. SK Avants A Margolin LA Warburton KA Hawkins J Shi 2001 Predictors of nonadherence to HIV-related medication regimens during methadone stabilization American Journal of Addictions 10 1 36 78
12. DR Bangsberg 2006 Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression Clinical Infectious Diseases 43 7 939941 10.1086/507526 (Pubitemid 44435526)
13. TR Barclay CH Hinkin SA Castellon KI Mason MJ Reinhard SD Marion, et al. 2007 Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status Health Psychology 26 1 40 49 17209696 10.1037/0278-6133.26.1.40 (Pubitemid 46072023)
14. RM Baron DA Kenny 1996 The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations Journal of Personality and Social Psychology 51 6 1173 1182 10.1037/0022-3514.51.6.1173
15. MK Baum C Rafie S Lai S Sales B Page A Campa 2009 Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users Journal of Acquired Immune Deficiency Syndrome 50 1 93 99 10.1097/QAI. 0b013e3181900129
16. WW Beatty VM Katzung VJ Moreland SJ Nixon 1995 Neuropsychological performance of recently abstinent alcoholics and cocaine abusers Drug and Alcohol Dependence 37 3 247 253 7796719 10.1016/0376-8716(94)01072-S 1:STN:280:DyaK2MzhslWqtw%3D%3D
17. RH Benedict JJ Mezhir K Walsh RG Hewitt 2000 Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life Archives of Clinical Neuropsychology 15 6 535 544 14590207 1:STN:280:DC%2BD3srhtlSjug%3D%3D (Pubitemid 30609707)
18. Benton, A., Hamsher, K., & Sivan, A. (1983). Multilingual aphasia examination (3rd ed.). Iowa City, IA: AJA Associates.
19. EG Bing MA Burnam D Longshore JA Fleishman CD Sherbourne AS London, et al. 2001 Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States Archives of General Psychiatry 58 8 721 728 11483137 10.1001/archpsyc.58.8.721 1:STN:280:DC%2BD3MvptFGitw%3D%3D (Pubitemid 32717795)
20. KI Bolla R Rothman JL Cadet 1999 Dose-related neurobehavioral effects of chronic cocaine use Journal of Neuropsychiatry and Clinical Neurosciences 11 3 361 369 10440013 1:CAS:528:DyaK1MXltlOnsLo%3D (Pubitemid 29408482)
21. Brandt, J., & Benedict, R. H. B. (2001). Hopkins verbal learning test-Revised professional manual. Lutz, FL: Psychological Assessment Resources, Inc.
22. BJ Brew F Gonzalez-Scarano 2007 HIV-associated dementia: An inconvenient truth Neurology 68 5 324 325 17261677 10.1212/01.wnl.0000252803.24176.76 (Pubitemid 46184207)
23. BJ Brew M Halman J Catalan N Sacktor RW Price S Brown, et al. 2007 Factors in AIDS dementia complex trial designs: Results and lessons from the abacavir trial PLoS Clinical Trials 2 3 13 10.1371/journal.pctr.0020013 (Pubitemid 46851656)
24. G Chander J Josephs JA Fleishman PT Korthuis P Gaist J Hellinger, et al. 2008 Alcohol use among HIV-infected persons in care: Results of a multi-site survey HIV Medicine 9 4 196 202 18366443 10.1111/j.1468-1293.2008.00545.x 1:STN:280:DC%2BD1czhtlOrug%3D%3D (Pubitemid 351467791)
25. L Chang GJ Wang ND Volkow T Ernst F Telang J Logan, et al. 2008 Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse Neuroimage 42 2 869 878 18579413 10.1016/j.neuroimage.2008.05.011
26. MA Chesney JR Ickovics DB Chambers AL Gifford J Neidig B Zwickl, et al. 2000 Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments AIDS Care 12 3 255 266 10928201 10.1080/09540120050042891 1:STN:280:DC%2BD3cvhslKgsA%3D%3D (Pubitemid 30426745)
27. S Clarke S Delamere L McCullough S Hopkins C Bergin F Mulcahy 2003 Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users HIV Medicine 4 1 33 37 12534957 10.1046/j.1468-1293.2003.00130.x 1:STN:280:DC%2BD3s%2FivVCntA%3D%3D (Pubitemid 37161534)
28. DB Clifford JC McArthur G Schifitto K Kieburtz MP McDermott S Letendre, et al. 2002 A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment Neurology 59 10 1568 1573 12451199 1:CAS:528:DC%2BD38XosVCmtr8%3D (Pubitemid 35387064)
29. JA Cook DD Grey JK Burke-Miller MH Cohen D Vlahov F Kapadia, et al. 2007 Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women Drug and Alcohol Dependence 89 1 74 81 17291696 10.1016/j.drugalcdep.2006.12.002 (Pubitemid 46602873)
30. S Dawes P Suarez CY Casey M Cherner TD Marcotte S Letendre, et al. 2008 Variable patterns of neuropsychological performance in HIV-1 infection Journal of Experimental and Clinical Neuropsychology 30 6 613 626 10.1080/ 13803390701565225 1:STN:280:DC%2BD1cvkslajsg%3D%3D (Pubitemid 351957691)
31. RS Durvasula HF Myers P Satz EN Miller H Morgenstern MA Richardson, et al. 2000 HIV-1, cocaine, and neuropsychological performance in African American men Journal of the International Neuropsychological Society 6 3 322 335 10824504 10.1017/S1355617700633076 1:STN:280:DC%2BD3c3osVGiug%3D%3D (Pubitemid 30303644)
32. Efron, B., & Tibshirani, R. J. (1993). An introduction to the bootstrap. Boca Raton, FL: Chapman & Hall.
33. W Fals-Stewart S Lucente 1994 Effect of neurocognitive status and personality functioning on length of stay in residential substance abuse treatment: An integrative study Psychology of Addictive Behaviors 8 3 179 190 10.1037/0893-164X.8.3.179
34. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). Structured clinical interview for DSM-IV axis I disorders, research version, Patient/Non-patient Edition, (SCID-I/P) or (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute.
35. CV Fletcher MA Testa RC Brundage MA Chesney R Haubrich EP Acosta, et al. 2005 Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359 Journal of Acquired Immune Deficiency Syndrome 40 3 301 306 10.1097/01.qai.0000180078.53321.6a (Pubitemid 41533070)
36. MF Folstein SE Folstein PR McHugh 1975 "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 12 3 189 198 1202204 10.1016/0022-3956(75)90026- 6 1:STN:280:DyaE28%2FntFKjtw%3D%3D
37. HC Fox ED Jackson R Sinha 2009 Elevated cortisol and learning and memory deficits in cocaine dependent individuals: Relationship to relapse outcomes Psychoneuroendocrinology 34 8 1198 1207 19375236 10.1016/j.psyneuen.2009.03.007 1:CAS:528:DC%2BD1MXptVSgs7o%3D
38. TP Giordano D Guzman R Clark ED Charlebois DR Bangsberg 2004 Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale HIV Clinical Trials 5 2 74 79 15116282 10.1310/JFXH-G3X2-EYM6- D6UG (Pubitemid 38697081)
39. RK Heaton I Grant N Butters DA White D Kirson JH Atkinson, et al. 1995 The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center Journal of the International Neuropsychological Society 1 3 231 251 9375218 10.1017/S1355617700000230 1:STN:280: DyaK1c%2Fkt1Orug%3D%3D
40. RK Heaton TD Marcotte MR Mindt J Sadek DJ Moore H Bentley, et al. 2004 The impact of HIV-associated neuropsychological impairment on everyday functioning Journal of the International Neuropsychological Society 10 3 317 331 15147590 10.1017/S1355617704102130 (Pubitemid 38779804)
41. Heaton, R. K., Miller, S. W., Taylor, M. J., & Grant, I. (2004b). Revised comprehensive norms for an expanded halstead-reitan battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources, Inc.
42. CH Hinkin TR Barclay SA Castellon AJ Levine RS Durvasula SD Marion, et al. 2007 Drug use and medication adherence among HIV-1 infected individuals AIDS and Behavior 11 2 185 194 16897351 10.1007/s10461-006-9152-0
43. CH Hinkin SA Castellon RS Durvasula DJ Hardy MN Lam KI Mason, et al. 2002 Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity Neurology 59 12 1944 1950 12499488 1:STN:280: DC%2BD38jjsFKgsw%3D%3D (Pubitemid 36076569)
44. CH Hinkin DJ Hardy KI Mason SA Castellon RS Durvasula MN Lam, et al. 2004 Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse AIDS 18 Supp 1 19 25
45. AL Hoff H Riordan L Morris V Cestaro M Wieneke R Alpert, et al. 1996 Effects of crack cocaine on neurocognitive function Psychiatry Research 60 2-3 167 176 8723307 10.1016/0165-1781(96)02758-8 1:CAS:528:DyaK28XjtVOrt78%3D (Pubitemid 26140175)
46. B Hult G Chana E Masliah I Everall 2008 Neurobiology of HIV International Review of Psychiatry 20 1 3 13 18240058 10.1080/09540260701862086 (Pubitemid 351196198)
47. SC Kalichman CM Amaral C Swetzes M Jones R Macy MO Kalichman, et al. 2009 A simple single-item rating scale to measure medication adherence: Further evidence for convergent validity Journal of the International Association of Physicians in AIDS Care 8 6 367 374 19952289 10.1177/1545109709352884
48. PT Korthuis LC Zephyrin JA Fleishman S Saha JS Josephs MM McGrath, et al. 2008 Health-related quality of life in HIV-infected patients: The role of substance use AIDS Patient Care and STDS 22 11 859 867 19025480 10.1089/apc.2008.0005
49. WH Kuo TE Wilson KM Weber V Madhava J Richardson R Delapenha, et al. 2004 Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS) AIDS Patient Care and STDS 18 12 702 713 15659881 10.1089/apc.2004.18.702 (Pubitemid 40066162)
50. AJ Levine DJ Hardy E Miller SA Castellon D Longshore CH Hinkin 2004 The effect of recent stimulant use on sustained attention in HIV-infected adults Journal of Clinical and Experimental Neuropsychology 28 1 29 42 10.1080/13803390490918066 (Pubitemid 43207238)
51. AJ Levine CH Hinkin SA Castellon KI Mason MN Lam A Perkins, et al. 2005 Variations in patterns of highly active antiretroviral therapy (HAART) adherence AIDS and Behavior 9 3 355 362 16088365 10.1007/s10461-005-9009-y (Pubitemid 41584987)
52. Lezac, M. D. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
53. H Liu LG Miller CE Golin T Wu NS Wenger AH Kaplan 2006 Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors Journal of Acquired Immune Deficiency Syndrome 41 3 315 322 10.1097/01.qai.0000197071. 77482.6e
54. ED London KR Bonson M Ernst S Grant 1999 Brain imaging studies of cocaine abuse: Implications for medication development Critical Reviews in Neurobiology 13 3 227 242 10803636 1:CAS:528:DC%2BD3cXjt1CqtbY%3D (Pubitemid 30265250)
55. TI Lovejoy JA Suhr 2009 The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: A systematic review Journal of Behav Medicine 32 5 389 405 10.1007/s10865-009-9212-9
56. M Lu SA Safren PR Skolnik WH Rogers W Coady H Hardy, et al. 2008 Optimal recall period and response task for self-reported HIV medication adherence AIDS and Behavior 12 1 86 94 17577653 10.1007/s10461-007-9261-4 (Pubitemid 351143454)
57. DP Mackinnon CM Lockwood J Williams 2004 Confidence limits for the indirect effect: Distribution of the product and resampling methods Multivariate Behavioral Research 39 1 99 20157642 10.1207/s15327906mbr3901-4
58. AT McLellan H Kushner D Metzger R Peters I Smith G Grissom, et al. 1992 The fifth edition of the addiction severity index Journal of Substance Abuse Treatment 9 3 199 213 1334156 10.1016/0740-5472(92)90062-S 1:STN:280: DyaK3s%2FpsFWluw%3D%3D
59. KL Medina PK Shear J Schafer 2006 Memory functioning in polysubstance dependent women Drug and Alcohol Dependence 84 3 248 255 16595165 10.1016/j.drugalcdep.2006.02.009 (Pubitemid 44287213)
60. Meyers, J. E., & Meyers, K. R. (1995). Rey complex figure test and recognition trial. Lutz, FL: Psychological Assessment Resources, Inc.
61. EJ Mills JB Nachega I Buchan J Orbinski A Attaran S Singh, et al. 2006 Adherence to antiretroviral therapy in sub-Saharan African and North American JAMA 296 6 679 690 16896111 10.1001/jama.296.6.679 1:CAS:528: DC%2BD28XotFagtbY%3D (Pubitemid 44200639)
62. JR Monterosso G Ainslie J Xu X Cordova CP Domier ED London 2007 Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task Human Brain Mapping 28 5 383 393 16944492 10.1002/hbm.20281 (Pubitemid 46717363)
63. DJ Moore E Masliah JD Rippeth R Gonzalez CL Carey M Cherner, et al. 2006 Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment AIDS 20 6 879 887 16549972 10.1097/01.aids.0000218552.69834.00 (Pubitemid 43731570)
64. A Palepu NJ Horton N Tibbetts S Meli JH Samet 2004 Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment Addiction 99 3 361 368 14982549 10.1111/j.1360-0443.2003.00670.x (Pubitemid 38333828)
65. MP Paulus NE Hozack BE Zauscher L Frank GG Brown DL Braff, et al. 2002 Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects Neuropsychopharmacology 26 1 53 63 11751032 10.1016/S0893-133X(01)00334-7 1:CAS:528:DC%2BD3MXpt1antbs%3D (Pubitemid 34075276)
66. KJ Preacher AF Hayes 2004 SPSS and SAS procedures for estimating indirect effects in simple mediation models Behavioral Research Methods, Instruments, and Computers 36 4 717 731 10.3758/BF03206553 (Pubitemid 40251423)
67. JG Rabkin M McElhiney SJ Ferrando W Van Gorp SH Lin 2004 Predictors of employment of men with HIV/AIDS: A longitudinal study Psychosomatic Medicine 66 1 72 78 14747640 10.1097/01.PSY.0000108083.43147.6D (Pubitemid 38146535)
68. CJ Reback S Larkins S Shoptaw 2003 Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men AIDS Care 15 6 775 785 14617499 10.1080/09540120310001618621 1:STN:280:DC%2BD3srjs1SrtA%3D%3D (Pubitemid 37494567)
69. M Reger R Welsh J Razani DJ Martin KB Boone 2002 A meta-analysis of the neuropsychological sequelae of HIV infection Journal of the International Neuropsychological Society 8 3 410 424 11939699 10.1017/S1355617702813212 (Pubitemid 34296099)
70. NR Reynolds J Sun HN Nagaraja AL Gifford AW Wu MA Chesney 2007 Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: A cross-protocol analysis Journal of Acquired Immune Deficiency Syndromes 46 4 402 409 18077832 10.1097/QAI.0b013e318158a44f (Pubitemid 350098690)
71. JD Rippeth RK Heaton CL Carey TD Marcotte DJ Moore R Gonzalez, et al. 2004 Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons Journal of the International Neuropsychological Society 10 1 1 14 14751002 10.1017/S1355617704101021 1:CAS:528:DC%2BD2cXmvVGltQ%3D%3D (Pubitemid 38128457)
72. M Rosselli A Ardila M Lubomski S Murray K King 2001 Personality profile and neuropsychological test performance in chronic cocaine-abusers International Journal of Neuroscience 110 1-2 55 72 11697211 10.3109/00207450108994221 1:STN:280:DC%2BD3MnksVOhtQ%3D%3D (Pubitemid 32961627)
73. P Roux MP Carrieri V Villes P Dellamonica I Poizot-Martin I Ravaux, et al. 2008 The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: Evidence from the MANIF2000 cohort study Addiction 103 11 1828 1836 18778390 10.1111/j.1360-0443.2008.02323.x
74. N Sacktor 2002 The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy Journal of Neurovirology 8 Suppl 2 115 121 12491162 10.1080/13550280290101094 1:CAS:528:DC%2BD3sXht1Sitbg%3D (Pubitemid 36097787)
75. G Schifitto BA Navia CT Yiannoutsos CM Marra L Chang T Ernst, et al. 2007 Memantine and HIV-associated cognitive impairment: A neuropsychological and proton magnetic resonance spectroscopy study AIDS 21 14 1877 1886 17721095 10.1097/QAD.0b013e32813384e8 1:CAS:528:DC%2BD2sXpsFahsL4%3D (Pubitemid 47329764)
76. G Schrimsher J Parker 2008 Changes in cognitive function during substance use disorder treatment Journal of Psychopathology and Behavioral Assessment 30 2 146 153 10.1007/s10862-007-9054-0 (Pubitemid 351641287)
77. DV Sheehan Y Lecrubier KH Sheehan P Amorim J Janavs E Weiller, et al. 1998 The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 Journal of Clinical Psychiatry 59 Suppl 30 22 33 9881538 (Pubitemid 29001829)
78. J Shuter JA Sarlo TJ Kanmaz RA Rode BS Zingman 2007 HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95% Journal of Acquired Immune Deficiency Syndrome 45 1 4 8 10.1097/QAI.0b013e318050d8c2 1:CAS:528:DC%2BD2sXksFOltro%3D (Pubitemid 46684437)
79. SL Simon C Domier J Carnell P Brethen R Rawson W Ling 2000 Cognitive impairment in individuals currently using methamphetamine American Journal on Addictions 9 3 222 231 11000918 10.1080/10550490050148053 1:STN:280: DC%2BD3cvkvVymtA%3D%3D
80. Smith, A. (1973). Symbol digit modalities test (SDMT). San Antonio: The Psych Corp.
81. Smith, A. (2007). Symbol digit modalities test manual. Los Angeles, CA: Western Psychological Services.
82. Sobell, L. C., & Sobell, M. B. (1996). Timeline follow back: A calendar method for assessing alcohol and drug use. Toronto, Canada: Addiction Research Foundation.
83. TM Solomon PN Halkitis 2008 Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men AIDS and Behavior 12 1 68 77 17636373 10.1007/s10461-007-9273-0 (Pubitemid 351143455)
84. G Teichner MD Horner RT Harvey 2001 Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients International Journal of Neuroscience 106 3/4 253 11264924 10.3109/00207450109149753 1:STN:280:DC%2BD3M7ms1emtQ%3D%3D
85. R Toomey MJ Lyons SA Eisen H Xian S Chantarujikapong LJ Seidman, et al. 2003 A twin study of the neuropsychological consequences of stimulant abuse Archives of General Psychiatry 60 3 303 310 12622664 10.1001/archpsyc.60.3.303 (Pubitemid 36307442)
86. V Tozzi P Balestra R Bellagamba A Corpolongo MF Salvatori U Visco-Comandini, et al. 2007 Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: Prevalence and risk factors Journal of Acquired Immune Deficiency Syndrome 45 2 174 182 10.1097/QAI.0b013e318042e1ee (Pubitemid 46869810)
87. JS Tucker M Orlando MA Burnam C Sherbourne F-Y Kung AL Gifford 2004 Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems Health Psychology 23 4 363 370 15264972 10.1037/0278-6133.23.4.363 (Pubitemid 38880168)
88. A Verdejo-Garcia M Perez-Garcia 2007 Profile of executive deficits in cocaine and heroin polysubstance users: Common and differential effects on separate executive components Psychopharmacology 190 4 517 530 17136401 10.1007/s00213-006-0632-8 1:CAS:528:DC%2BD2sXhtFygs7s%3D (Pubitemid 46204469)
89. ND Volkow JS Fowler GJ Wang JM Swanson 2004 Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications Molecular Psychiatry 9 6 557 569 15098002 10.1038/sj.mp.4001507 1:CAS:528: DC%2BD2cXkt1Gnt7Y%3D (Pubitemid 38850435)
90. GJ Wagner 2002 Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries AIDS Patient Care and STDS 16 12 599 608 12542933 10.1089/108729102761882134 (Pubitemid 36008059)
91. D Waldrop-Valverde DL Jones D Jayaweera P Gonzalez J Romero RL Ownby 2009 Gender differences in medication management capacity in HIV infection: The role of health literacy and numeracy AIDS and Behavior 13 1 46 52 18618237 10.1007/s10461-008-9425-x
92. Waldrop-Valverde, D., Osborn, C. Y., Rodriguez, A., Rothman, R. L., Kumar, M., & Jones, D. L. (2009). Numeracy skills explain racial differences in HIV medication management. AIDS and Behavior, Epub ahead of print (Aug 6), 1-7.
93. MP Webber EE Schoenbaum MN Gourevitch D Buono RS Klein 1999 A prospective study of HIV disease progression in female and male drug users AIDS 13 2 257 262 10202832 10.1097/00002030-199902040-00014 1:STN:280:DyaK1M3hslCrsA%3D%3D (Pubitemid 29050414)